Jatrorrhizine has a considerable effect to prevent cardiac remodeling after MI, which attributes to its capability to suppress apoptosis through inhibiting p53/Bax/Bcl-2 signaling pathway and weaken cardiac fibrosis through inhibiting TGF-β1/Smad2/3 signaling pathway. This evidence concerns the gene TP53 and myocardial infarction.